| Oncolytic viruses as engineering platforms for combination immunotherapy K Twumasi-Boateng, JL Pettigrew, YYE Kwok, JC Bell, BH Nelson Nature Reviews Cancer 18 (7), 419-432, 2018 | 361 | 2018 |
| Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer DA Wick, JR Webb, JS Nielsen, SD Martin, DR Kroeger, K Milne, ... Clinical Cancer Research 20 (5), 1125-1134, 2014 | 171 | 2014 |
| Low mutation burden in ovarian cancer may limit the utility of neoantigen-targeted vaccines SD Martin, SD Brown, DA Wick, JS Nielsen, DR Kroeger, ... PloS one 11 (5), e0155189, 2016 | 140 | 2016 |
| Transcriptional profiling identifies a role for BrlA in the response to nitrogen depletion and for StuA in the regulation of secondary metabolite clusters in Aspergillus fumigatus K Twumasi-Boateng, Y Yu, D Chen, FN Gravelat, WC Nierman, ... Eukaryotic cell 8 (1), 104-115, 2009 | 135 | 2009 |
| Oncolytic vesicular stomatitis virus expressing interferon-σ has enhanced therapeutic activity MC Bourgeois-Daigneault, DG Roy, T Falls, K Twumasi-Boateng, ... Molecular Therapy-Oncolytics 3, 2016 | 86 | 2016 |
| The Developmental Intestinal Regulator ELT-2 Controls p38-Dependent Immune Responses in Adult C. elegans DHS Block, K Twumasi-Boateng, HS Kang, JA Carlisle, A Hanganu, ... PLoS genetics 11 (5), e1005265, 2015 | 55 | 2015 |
| An age‐dependent reversal in the protective capacities of JNK signaling shortens Caenorhabditis elegans lifespan K Twumasi‐Boateng, TW Wang, L Tsai, KH Lee, A Salehpour, S Bhat, ... Aging cell 11 (4), 659-667, 2012 | 43 | 2012 |
| Dissociation of immune responses from pathogen colonization supports pattern recognition in C. elegans K Twumasi-Boateng, M Shapira PLoS One 7 (4), e35400, 2012 | 28 | 2012 |
| FOS-1 functions as a transcriptional activator downstream of the C. elegans JNK homolog KGB-1 Z Zhang, L Liu, K Twumasi-Boateng, DHS Block, M Shapira Cellular Signalling 30, 1-8, 2017 | 18 | 2017 |
| Publisher Correction: Oncolytic viruses as engineering platforms for combination immunotherapy K Twumasi-Boateng, JL Pettigrew, YYE Kwok, JC Bell, BH Nelson Nature reviews Cancer 18 (8), 526-526, 2018 | 15 | 2018 |
| Automated separation of C. elegans variably colonized by a bacterial pathogen K Twumasi-Boateng, M Berg, M Shapira JoVE (Journal of Visualized Experiments), e51090, 2014 | 3 | 2014 |
| Sensing and Responding to Stress Stimuli in Caenorhabditis elegans: Implications for Aging and Immunity K Twumasi-Boateng University of California, Berkeley, 2012 | 1 | 2012 |
| Towards Effective CAIX-targeted Radionuclide and Checkpoint Inhibition Combination Therapy for Advanced Clear Cell Renal Cell Carcinoma SC Kleinendorst, E Oosterwijk, J Molkenboer-Kuenen, C Frielink, ... bioRxiv, 2024.02. 16.580614, 2024 | | 2024 |
| Preclinical evaluation of targeted radionuclide therapy combined with immune checkpoint inhibition E Oosterwijk, S Kleidendorst, M Konijnenberg, R Merkx, ... European Urology 83, S1489, 2023 | | 2023 |
| Anti-oncolytic virus antigen antibodies and methods of using same EJ Cummins, JP Bergqvist, B Nelson, K Twumasi-Boateng, YYE Kwok, ... US Patent App. 17/642,089, 2023 | | 2023 |
| Preclinical evaluation of targeted radionuclide therapy combined with immune checkpoint inhibition S Kleinendorst, M Konijnenberg, R Merkx, K Twumasi-Boateng, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1), S58-S59, 2022 | | 2022 |
| Potentiation of Immune Checkpoint Inhibition with Molecular-Targeted Radiation S Kleinendorst, P Chandler, E Oosterwijk, M Konijnenberg, ... Journal of Nuclear Medicine 63 (supplement 2), 4039-4039, 2022 | | 2022 |
| MG1 Maraba boost following adenovirus prime generates tumor antigen-specific T cells which are potentiated by anti-PD-1 antibody combination K Stephenson, K Twumasi-Boateng, A Patrick, C Breitbach, M Burgess, ... Cancer Research 79 (13_Supplement), 1449-1449, 2019 | | 2019 |
Brad H NelsonDirector, Deeley Research Centre, BC Cancer AgencyVerified email at bccancer.bc.ca
